{
    "nctId": "NCT00656019",
    "briefTitle": "Development of Vitamin D as a Therapy for Breast Cancer - Phase 2",
    "officialTitle": "Development of Vitamin D as a Therapy for Breast Cancer - Phase 2",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 63,
    "primaryOutcomeMeasure": "Correlation of Vitamin D Levels, Prognostic Factors, and Gene Expression Profile in Patients With Breast Cancer",
    "eligibilityCriteria": "INCLUSION CRITERIA:\n\n* Undergoing core needle biopsy for a breast abnormality suspicious for breast cancer.\n* Has undergone a core needle biopsy demonstrating breast cancer and has not yet had any further therapy, provided the core needle biopsy is available for analysis.\n* No prior therapy for breast cancer within the past 5 years.\n* 18 years of age or older.\n* Ability to understand and the willingness to sign a written informed consent document.\n\nEXCLUSION CRITERIA:\n\n* History of parathyroid disease, hypercalcemia, or kidney stones.\n* Supplemental vitamin D other than from a standard multiple vitamin or from standard formulations of calcium and vitamin D (eg, calcium citrate with vitamin D) within the prior 6 months.\n* History of renal failure requiring dialysis or kidney transplantation.\n* Pregnant or nursing\n* Receiving supplemental calcium \\> 1200 mg calcium per day during study.\n* Initial treatment of breast cancer will not be with breast-conserving surgery or mastectomy.\n* Locally-advanced breast cancer\n* Plans for neoadjuvant chemotherapy, hormonal therapy, or other systemic therapy\n* Plans for preoperative radiation therapy\n* Plans for breast cancer surgery, and does not allow for at least 10 days of vitamin D intervention.\n* Any condition potentially interfering with subjects ability to comply with taking study medication.\n* Any medical condition that would potentially interfere with vitamin D absorption, such as celiac sprue, ulcerative colitis.\n* Current participation in another research study that would increase risk to subject, in the opinion of the investigators",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}